The adoption of telehealth services has boomed in the pandemic — with usage up 38-fold since January 2020, according to a report by McKinsey. While a lot of the attention has been on companies that are building the communications layer between consumers and clinicians, there are also a wave of companies building devices to expand what can be monitored and addressed in a telehealth environment.
In one of the latest developments, Bisu — a Tokyo-headquartered healthcare startup that has built a lab-grade testing device that can be used at home for diagnostics that translate into actionable health data — has raised $3.2 million. The seed …
